| Primary |
| Drug Use For Unknown Indication |
35.0% |
| Depression |
20.0% |
| Dysthymic Disorder |
15.0% |
| Schizophrenia |
10.0% |
| Arteritis |
5.0% |
| Dyslipidaemia |
5.0% |
| Hypothyroidism |
5.0% |
| Insomnia |
5.0% |
|
| Fall |
33.3% |
| International Normalised Ratio Increased |
33.3% |
| Lymphopenia |
33.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.4% |
| Product Used For Unknown Indication |
13.8% |
| Depression |
6.9% |
| Dementia Alzheimer's Type |
5.6% |
| Hiv Infection |
4.5% |
| Abnormal Behaviour |
4.0% |
| Anxiety |
4.0% |
| Epilepsy |
3.8% |
| Intentional Overdose |
3.6% |
| Psychotic Disorder |
3.6% |
| Infection |
2.9% |
| Antiretroviral Therapy |
2.7% |
| Bipolar Disorder |
2.7% |
| Pneumonia |
2.7% |
| Thrombosis Prophylaxis |
2.2% |
| Major Depression |
1.8% |
| Calcium Deficiency |
1.6% |
| Sensation Of Heaviness |
1.6% |
| Vitamin D Deficiency |
1.6% |
| Atrial Fibrillation |
1.3% |
|
| Somnolence |
8.4% |
| Talipes |
8.4% |
| Haemolytic Anaemia |
7.2% |
| Respiratory Distress |
7.2% |
| Thrombocytopenia |
7.2% |
| Cytolytic Hepatitis |
6.0% |
| Sudden Death |
6.0% |
| Cholestasis |
4.8% |
| Hyponatraemia |
4.8% |
| Psychomotor Skills Impaired |
4.8% |
| Vitamin B12 Deficiency |
4.8% |
| Weight Increased |
4.8% |
| Anticonvulsant Drug Level Above Therapeutic |
3.6% |
| Fall |
3.6% |
| Suicide Attempt |
3.6% |
| Transaminases Increased |
3.6% |
| Weight Decreased |
3.6% |
| Colitis Microscopic |
2.4% |
| Confusional State |
2.4% |
| Hepatic Enzyme Increased |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.0% |
| Product Used For Unknown Indication |
16.8% |
| Bipolar Disorder |
10.1% |
| Depression |
8.2% |
| Psychotic Disorder |
6.8% |
| Anxiety |
4.9% |
| Hiv Infection |
4.6% |
| Schizophrenia |
4.1% |
| Bipolar I Disorder |
2.8% |
| Insomnia |
2.0% |
| Pain |
2.0% |
| Affective Disorder |
1.9% |
| Hypertension |
1.9% |
| Colon Cancer |
1.6% |
| Epilepsy |
1.4% |
| Sleep Disorder |
1.4% |
| Abnormal Behaviour |
1.3% |
| Hypothyroidism |
1.3% |
| Rheumatoid Arthritis |
1.1% |
| Atrial Fibrillation |
0.9% |
|
| Vomiting |
10.9% |
| Tremor |
7.6% |
| Renal Failure |
6.5% |
| Thrombocytopenia |
6.5% |
| Ultrasound Antenatal Screen Abnormal |
6.5% |
| Upper Limb Fracture |
6.5% |
| Tachycardia |
5.4% |
| Dyspnoea |
4.3% |
| Hepatocellular Injury |
4.3% |
| Pulmonary Embolism |
4.3% |
| Somnolence |
4.3% |
| Transaminases Increased |
4.3% |
| Weight Decreased |
4.3% |
| Weight Increased |
4.3% |
| Hyporeflexia |
3.3% |
| Intestinal Obstruction |
3.3% |
| Malaise |
3.3% |
| Pneumonia Aspiration |
3.3% |
| Pyrexia |
3.3% |
| Sinus Bradycardia |
3.3% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Aggression |
28.6% |
| Type 2 Diabetes Mellitus |
14.3% |
| Insomnia |
7.1% |
|
| Drug Interaction |
33.3% |
| Psychomotor Retardation |
33.3% |
| Urinary Retention |
33.3% |
|
